Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 220,645	$ 226,142
Prepaid expenses and other current assets	40,632	43,352
Total current assets	261,277	269,494
Total assets	261,277	269,494
Current liabilities:
Accounts payable	133,464	113,513
Derivative liability	46,700	104,300
Accrued compensation	2,399,132	1,391,297
Accrued consulting	753,570	474,275
Accrued expenses and other	584,808	249,972
Total current liabilities	3,917,674	2,333,357
Convertible notes, net	1,228,361	735,148
Total liabilities	5,146,035	3,068,505
Commitments and contingencies
Stockholders’ deficit:
Common stock, $0.00001 par value: 100,000,000 shares authorized: 7,242,137 and 7,241,137 shares issued and outstanding at December 31, 2022 and 2021, respectively	72	72
Additional paid-in capital	2,023,271	1,728,148
Accumulated deficit	(6,908,102)	(4,527,232)
Total stockholders’ deficit	(4,884,758)	(2,799,011)
Total liabilities and stockholders’ deficit	261,277	269,494
Series A Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock, value	0	0
Series B Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock, value	$ 1	$ 1